1. Home
  2. TUYA vs DBVT Comparison

TUYA vs DBVT Comparison

Compare TUYA & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuya Inc. each representing one

TUYA

Tuya Inc. each representing one

HOLD

Current Price

$2.42

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$20.40

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUYA
DBVT
Founded
2014
2002
Country
China
France
Employees
N/A
90
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
TUYA
DBVT
Price
$2.42
$20.40
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$3.49
$31.75
AVG Volume (30 Days)
1.8M
225.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,151,000.00
Revenue This Year
$13.29
$65.50
Revenue Next Year
$14.65
$47.02
P/E Ratio
$27.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.87
$3.91
52 Week High
$3.95
$26.19

Technical Indicators

Market Signals
Indicator
TUYA
DBVT
Relative Strength Index (RSI) 54.31 45.30
Support Level $2.29 $20.23
Resistance Level $2.44 $25.00
Average True Range (ATR) 0.11 1.56
MACD -0.01 -0.26
Stochastic Oscillator 32.73 35.30

Price Performance

Historical Comparison
TUYA
DBVT

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: